Annual Total Debt
$1.40 B
-$220.55 M-13.64%
31 December 2023
Summary:
Sarepta Therapeutics annual total debt is currently $1.40 billion, with the most recent change of -$220.55 million (-13.64%) on 31 December 2023. During the last 3 years, it has risen by +$323.95 million (+30.19%). SRPT annual total debt is now -13.64% below its all-time high of $1.62 billion, reached on 31 December 2022.SRPT Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$1.40 B
+$27.65 M+2.02%
30 September 2024
Summary:
Sarepta Therapeutics quarterly total debt is currently $1.40 billion, with the most recent change of +$27.65 million (+2.02%) on 30 September 2024. Over the past year, it has increased by +$26.06 million (+1.90%). SRPT quarterly total debt is now -13.59% below its all-time high of $1.62 billion, reached on 31 December 2022.SRPT Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | +1.9% |
| 3 y3 years | +30.2% | +20.6% |
| 5 y5 years | +232.1% | +187.5% |
SRPT Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.6% | +30.2% | -13.6% | +22.9% |
| 5 y | 5 years | -13.6% | +232.1% | -13.6% | +187.5% |
| alltime | all time | -13.6% | -13.6% |
Sarepta Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.40 B(+2.0%) |
| June 2024 | - | $1.37 B(-0.7%) |
| Mar 2024 | - | $1.38 B(-1.2%) |
| Dec 2023 | $1.40 B(-13.6%) | $1.40 B(+1.8%) |
| Sept 2023 | - | $1.37 B(+0.5%) |
| June 2023 | - | $1.36 B(+5.9%) |
| Mar 2023 | - | $1.29 B(-20.4%) |
| Dec 2022 | $1.62 B(+40.2%) | $1.62 B(+2.5%) |
| Sept 2022 | - | $1.58 B(+38.4%) |
| June 2022 | - | $1.14 B(+0.2%) |
| Mar 2022 | - | $1.14 B(-1.4%) |
| Dec 2021 | $1.15 B(+7.5%) | $1.15 B(-0.4%) |
| Sept 2021 | - | $1.16 B(+0.0%) |
| June 2021 | - | $1.16 B(+0.6%) |
| Mar 2021 | - | $1.15 B(+7.4%) |
| Dec 2020 | $1.07 B(+47.0%) | $1.07 B(+39.6%) |
| Sept 2020 | - | $768.70 M(+0.3%) |
| June 2020 | - | $766.56 M(+1.8%) |
| Mar 2020 | - | $753.22 M(+3.2%) |
| Dec 2019 | $729.62 M(+73.5%) | $729.62 M(+50.1%) |
| Sept 2019 | - | $486.16 M(+1.0%) |
| June 2019 | - | $481.25 M(+0.7%) |
| Mar 2019 | - | $477.92 M(+13.6%) |
| Dec 2018 | $420.55 M(-2.4%) | $420.55 M(+1.2%) |
| Sept 2018 | - | $415.45 M(-5.5%) |
| June 2018 | - | $439.44 M(+2.0%) |
| Mar 2018 | - | $430.81 M(-0.1%) |
| Dec 2017 | $431.05 M(+2569.0%) | $431.05 M(+1278.0%) |
| Sept 2017 | - | $31.28 M(+178.9%) |
| June 2017 | - | $11.22 M(-18.1%) |
| Mar 2017 | - | $13.69 M(-15.2%) |
| Dec 2016 | $16.15 M(-31.0%) | $16.15 M(-13.2%) |
| Sept 2016 | - | $18.60 M(-8.0%) |
| June 2016 | - | $20.22 M(-3.6%) |
| Mar 2016 | - | $20.98 M(-10.3%) |
| Dec 2015 | $23.40 M(+269.8%) | $23.40 M(+0.5%) |
| Sept 2015 | - | $23.29 M(-9.3%) |
| June 2015 | - | $25.66 M(+302.2%) |
| Mar 2015 | - | $6.38 M(+0.8%) |
| Dec 2014 | $6.33 M(+279.4%) | $6.33 M(+0.8%) |
| Sept 2014 | - | $6.28 M(+287.1%) |
| June 2014 | - | $1.62 M(-1.5%) |
| Mar 2014 | - | $1.65 M(-1.4%) |
| Dec 2013 | $1.67 M(-5.1%) | $1.67 M(-1.3%) |
| Sept 2013 | - | $1.69 M(-1.3%) |
| June 2013 | - | $1.71 M(-1.3%) |
| Mar 2013 | - | $1.74 M(-1.3%) |
| Dec 2012 | $1.76 M(-4.6%) | $1.76 M(-1.2%) |
| Sept 2012 | - | $1.78 M(-1.2%) |
| June 2012 | - | $1.80 M(-1.2%) |
| Mar 2012 | - | $1.82 M(-1.1%) |
| Dec 2011 | $1.84 M(-4.2%) | $1.84 M(-1.1%) |
| Sept 2011 | - | $1.86 M(-1.1%) |
| June 2011 | - | $1.88 M(-1.1%) |
| Mar 2011 | - | $1.90 M(-1.0%) |
| Dec 2010 | $1.92 M | $1.92 M(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $1.94 M(-1.0%) |
| June 2010 | - | $1.96 M(-36.5%) |
| Mar 2010 | - | $3.09 M(+54.4%) |
| Dec 2009 | $2.00 M(-22.7%) | $2.00 M(-1.2%) |
| Sept 2009 | - | $2.03 M(-22.6%) |
| June 2009 | - | $2.62 M(+1.2%) |
| Mar 2009 | - | $2.59 M(-0.2%) |
| Dec 2008 | $2.59 M(+20.9%) | $2.59 M(+24.0%) |
| Sept 2008 | - | $2.09 M(-0.8%) |
| June 2008 | - | $2.11 M(-0.8%) |
| Mar 2008 | - | $2.12 M(-0.8%) |
| Dec 2007 | $2.14 M(>+9900.0%) | $2.14 M(-0.8%) |
| Sept 2007 | - | $2.16 M(-0.8%) |
| June 2007 | - | $2.18 M(>+9900.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) |
| June 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2003 | - | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) |
| Dec 1999 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1999 | - | $0.00(0.0%) |
| June 1999 | - | $0.00(0.0%) |
| Mar 1999 | - | $0.00(0.0%) |
| Dec 1998 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1998 | - | $0.00(0.0%) |
| June 1998 | - | $0.00(0.0%) |
| Mar 1998 | - | $0.00(0.0%) |
| Dec 1997 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1997 | - | $0.00(0.0%) |
| June 1997 | - | $0.00(0.0%) |
| Mar 1997 | - | $0.00 |
| Dec 1996 | $0.00 | - |
FAQ
- What is Sarepta Therapeutics annual total debt?
- What is the all time high annual total debt for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual total debt year-on-year change?
- What is Sarepta Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly total debt year-on-year change?
What is Sarepta Therapeutics annual total debt?
The current annual total debt of SRPT is $1.40 B
What is the all time high annual total debt for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total debt is $1.62 B
What is Sarepta Therapeutics annual total debt year-on-year change?
Over the past year, SRPT annual total debt has changed by -$220.55 M (-13.64%)
What is Sarepta Therapeutics quarterly total debt?
The current quarterly total debt of SRPT is $1.40 B
What is the all time high quarterly total debt for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total debt is $1.62 B
What is Sarepta Therapeutics quarterly total debt year-on-year change?
Over the past year, SRPT quarterly total debt has changed by +$26.06 M (+1.90%)